Effect of transspinal direct current stimulation on afferent pain signalling in humans.


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 26 02 2020
revised: 24 04 2020
accepted: 26 04 2020
pubmed: 19 5 2020
medline: 21 10 2020
entrez: 19 5 2020
Statut: ppublish

Résumé

Anodal transspinal Direct Current Stimulation (tsDCS) has been suggested as a means to treat neuropathic pain by reducing pain signalling/processing and Laser Evoked Potentials (LEPs) likewise as a method to evaluate such reduction. However, results in previous studies are disagreeing. To evaluate these claims using rigorous methodology, LEPs were evoked from hands and feet in healthy volunteers. The N2 potential and three psychophysic parameters (general- and pinprick pain, warmth) were used to evaluate the signalling and appreciation of pain respectively. This was made at three time points; at baseline, directly- and 30 min after low thoracic tsDCS (20 min, 2.5 mA, cathode on shoulder). The study was randomized, cross over, double blinded and placebo controlled. At the group level, low thoracic anodal tsDCS produced reduced perceptions of all three tested pain qualities from the foot (p < 0.05 - p < 0.001). These reductions began during stimulation and became more pronounced during the 30 min after its cessation (p < 0.05 - p < 0.01). The LEP parameter alteration mirroring these changes was latency prolongation (p < 0.05 - p < 0.001) whereas amplitude reductions were in par with placebo stimulation. Similar but less pronounced and only transient (during stimulation, p < 0.05 - p < 0.001) changes, were seen for hand stimulation. The interindividual variation was large. The findings indicate that anodal tsDCS may become a technique to treat neuropathic pain by reducing pain signalling/processing and LEPs likewise a method to evaluate such reduction.

Identifiants

pubmed: 32418809
pii: S0967-5868(20)30458-6
doi: 10.1016/j.jocn.2020.04.116
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

163-167

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Magnus Thordstein (M)

Department of Clinical Neurophysiology and Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden. Electronic address: magnus.thordstein@liu.se.

Mats Svantesson (M)

Department of Clinical Neurophysiology and Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.

Hedayat Rahin (H)

Department of Clinical Neurophysiology and Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH